Logo

Parmax Pharma Limited Share Price

BSE: 540359
|
Pharmaceuticals
₹ 82.88
+₹1.62 (1.99%)
1D
Last updated 03 Jul, 2026, 15:15 IST

Parmax Pharma Limited Share Price Today

As of 5 Jul 2026, Parmax Pharma Limited share price is ₹82.88. The stock opened at ₹82.88, compared to its previous close of ₹81.26. During today's trading session, Parmax Pharma Limited share price moved in the range of ₹82.88 to ₹82.88, with an average price of ₹82.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹22.60 and a high of ₹82.88.

₹82.88
1.99% up today
₹82.88
1D LOW
1D HIGH

Parmax Pharma Limited Returns Calculator

Open
₹82.88
High
₹82.88
Low
₹82.88
Prev. close
₹81.26
Circuit
L
H
₹81.23
₹84.53
52-week
L
H
₹22.60
₹82.88

Parmax Pharma Limited Shareholder Returns

Parmax Pharma Limited Share Price History

Mkt Cap Cr
30.40
P/E
-7.31
P/B
0.00
ROE
67.65%
D/E
-1.87
ROCE
-85.76%
Div. Yield
0.00%
EPS(TTM)
-11.12
Turnover
2.26
EV/EBITDA
-11.52
Net Margin
0.00%
Op. Margin
0.00%
ROA
-14.80%
Quick Ratio
0.00
Curr. Ratio
0.74
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Parmax Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Parmax Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Parmax Pharma Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹28.20₹11.05₹15.42₹18.25
Other Income₹0.04₹0.05₹0.04₹0.06
Total Revenue₹28.24₹11.10₹15.46₹18.31
Total Expenses₹29.57₹16.76₹15.42₹18.01
Profit Before Tax-₹2.40-₹5.66₹0.05₹0.30
Tax-₹0.30₹0.09₹0.15₹0.16
Profit After Tax-₹2.09-₹5.75-₹0.10₹0.14
EPS - Basic-₹5.60-₹34.56-₹0.28₹0.38
EPS - Diluted-₹5.60-₹34.56-₹0.28₹0.38

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹2.40-₹5.66₹0.05₹0.30
Income before WC changes-₹0.59-₹4.07₹1.74₹2.02
Change in Assets-₹4.19₹1.80-₹1.23₹2.66
Change in Liabilities₹3.83₹2.08-₹0.18-₹3.93
Change in WC-₹0.36₹3.88-₹1.41-₹1.27
Cash flow from Operations-₹0.96-₹0.20₹0.33₹0.75
Cash flow from Investing-₹0.70-₹1.59-₹0.94-₹1.53
Cash flow from Financing₹1.40₹1.43-₹0.04-₹0.91
Total Cash Flow-₹0.26-₹0.36-₹0.65-₹1.69
Cash (Start of the year)₹0.05₹0.41₹1.05₹2.75
Cash (End of the year)-₹0.21₹0.05₹0.41₹1.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹8.75₹9.56₹10.08₹11.42
Current Assets₹10.00₹5.77₹7.53₹6.56
Total Assets₹18.75₹15.33₹17.61₹17.97
Current Liabilities₹13.04₹9.21₹7.14₹7.31
Net Current Asset-₹3.03-₹3.44₹0.39-₹0.75
Non-Current Liabilities₹7.70₹6.01₹4.62₹4.70
Equity Capital-₹1.99₹0.11₹5.86₹5.96
Total Equity & Liabilities₹18.75₹15.33₹17.61₹17.97
* All values are in INR Crore
Qty
Bid
238667
82.88
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 238667
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
5
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
90.8
Bullish
ATR (14)
1.68
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
85.78
Bearish
UO(9)
96.44
Bearish
ROC(12)
26.75
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
79.7
79.74
10D
75.95
75.69
20D
66.87
67.79
50D
47.41
53.55
100D
39.01
44.71

About Parmax Pharma Limited

Parmax Pharma Limited logo
ISIN
INE240T01014
Sector Market Cap
₹ 30.4 Cr

Parmax Pharma Ltd is an India-based company, which is engaged in active pharmaceutical ingredients (API) and contract manufacturing operations (CMO) business. It uses quality by design techniques to produce complex molecules enabling customers to create formulations. The Company’s manufacturing units run in accordance with current good manufacturing practices (cGMP). Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Ormeloxifene Hydrochloride I.P., Milnacipram HCl, Calciumpoly Carbophil usp, Levosulpride, Paliperidone, Edaravone, Lacosamide, Iloperidone, Prasugrel HCl, 2-Acetyl Thiophene, Morpholine Hydrochloride, Camphor Sulfonyl Chloride, ISB-I (2-Chlorobenzaldehyde-5-Sulfonic acid disodium salt), Benzaldehyde-2, 5-Di-Sulfonic acid disodium salt, 2-picolinoxylidide, 4-Octyl amino pyridine (4-OAP), Sitagliptin phosphate Monohydrate API, Solifenacin Succinate API, Vilazodone Hydrochloride API, and Azelnidipine API.

Know more
Promoters
30.80%
FII
0.00%
Other DII
0.00%
Retail and other
69.20%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Parmax Pharma Limited logo
Parmax Pharma Limited
Pharmaceuticals
Add Stock
Add Another

FAQs on Parmax Pharma Limited Share Price